Washington Post
Leukemia vaccine passes key trial, adding to breakthrough year for cancer drugs
Tuesday, November 17, 2026
A leukemia vaccine reduced the risk of death for patients with acute myeloid leukemia in a clinical trial, according to the drugmaker that developed it. The vaccine's approval status and trial details, including patient numbers and the size of the mortality reduction, were not specified in the available information. The result adds to a series of cancer drug approvals in 2026.
Original reporting:
